Preliminary Evaluation of the Efficacy and Local Tolerability of Injectable Diclofenac at 5, 12.5, 25 and 50 mg/mL, Administered Locally Prior to Surgery for the Prevention of Post-operative Pain After Third Molar Surgery

Trial Profile

Preliminary Evaluation of the Efficacy and Local Tolerability of Injectable Diclofenac at 5, 12.5, 25 and 50 mg/mL, Administered Locally Prior to Surgery for the Prevention of Post-operative Pain After Third Molar Surgery

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Oct 2014

At a glance

  • Drugs Diclofenac (Primary)
  • Indications Postoperative pain
  • Focus Biomarker; Therapeutic Use
  • Acronyms DP4
  • Sponsors IBSA
  • Most Recent Events

    • 17 Nov 2012 New source identified and integrated (European Clinical Trials Database record: EudraCT2012-002996-32).
    • 12 Nov 2012 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database.
    • 06 Nov 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top